We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 07, 2021

Liver Disease Risk in Patients With Psoriasis, Psoriatic Arthritis, or Rheumatoid Arthritis Receiving Methotrexate

Journal of the American Academy of Dermatology

 

Additional Info

Journal of the American Academy of Dermatology
Risk of Liver Disease in Patients With Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis Receiving Methotrexate: A Population-Based Study
J Am Acad Dermatol 2021 Feb 16;[EPub Ahead of Print], JM Gelfand, J Wan, H Zhang, DB Shin, A Ogdie, MN Syed, A Egeberg

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading